Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco

BACKGROUND: Opioid overdose is a leading cause of death in persons experiencing homelessness (PEH), despite effective medications for opioid use disorder (OUD). In 2016, the San Francisco Street Medicine Team piloted a low barrier buprenorphine program with the primary goal of engaging and retaining...

Descripción completa

Detalles Bibliográficos
Autores principales: Carter, Jamie, Zevin, Barry, Lum, Paula J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501460/
https://www.ncbi.nlm.nih.gov/pubmed/31060600
http://dx.doi.org/10.1186/s13722-019-0149-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501460/
https://www.ncbi.nlm.nih.gov/pubmed/31060600
http://dx.doi.org/10.1186/s13722-019-0149-1

Ejemplares similares